Conference Coverage

Overweight or obese HIV-positive people randomized to an internet behavioral weight-loss program lost significantly more weight than those randomized to an internet educational program.

Among people starting their first antiretroviral therapy regimen, more advanced HIV disease and black race independently predicted severe weight gain through 96 weeks of follow-up.

Low body mass index and obesity, but not being overweight, predicted mortality and serious non-AIDS events, including cardiovascular disease and cancers, in a 41,149-person D:A:D study analysis.

Avoiding traditional cardiovascular risk factors -- high total cholesterol, hypertension and smoking -- would have the biggest impact on cutting myocardial infarction (MI) rates in North Americans with HIV.

Women with HIV tend to perform worse than HIV-negative women on cognitive performance tests, even after many years on treatment, new research finds -- but trends differed depending on the test and on women's treatment success.

Researchers at CROI 2017 reported no evidence of accelerating brain aging in HIV-positive people in ART, based on highly sensitive brain imaging scans and cognitive testing over two years.

Hepatitis C treatment for HIV/HCV co-infected people, sexual transmission of HCV and other news from the AASLD Liver Meeting.

The antibiotic, when taken within 72 hours of condomless sex, can reduce the risk of bacterial sexually transmitted infections by 47%, new research presented at CROI this week showed.

"It is critical that patients and patient advocates work closely with medical, public health and health economics experts to speak out about our nation's ability to respond to viral hepatitis," Project Inform states.

Hepatitis C testing rates increased significantly following the enactment of the New York State Hepatitis C Testing Law on Jan. 1, 2014, and linkage-to-care rates also increased, a recent study finds.